<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">4403</id>
  <title>T3D4349</title>
  <common-name>Galactitol</common-name>
  <description>Galactitol is a naturally occurring product of plants obtained following reduction of galactose. It appears as a white crystalline powder with a slight sweet taste. It may form in excess in the lens of the eye in galactosemias a deficiency of galactokinase.</description>
  <cas>608-66-2</cas>
  <pubchem-id>11850</pubchem-id>
  <chemical-formula>C6H14O6</chemical-formula>
  <weight nil="true"/>
  <appearance>White powder.</appearance>
  <melting-point>189.5°C</melting-point>
  <boiling-point></boiling-point>
  <density nil="true"/>
  <solubility>31,0 mg/mL at 15°C</solubility>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity>Accumulation of galactitol in the body has been shown to be toxic. Accumulation of galactitol in the lens causes the osmotic phenomena and results in cataract formation. It may form in excess in the lens of the eye in galactosemias, a deficiency of galactokinase.</mechanism-of-toxicity>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity>No indication of carcinogenicity to humans (not listed by IARC).</carcinogenicity>
  <use-source>This is an endogenously produced metabolite found in the human body. It is used in metabolic reactions, catabolic reactions or waste generation.</use-source>
  <min-risk-level nil="true"/>
  <health-effects>Chronically high levels of galactitol are associated with at least 2 inborn errors of metabolism including: Galactosemia and Galactosemia type II.</health-effects>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2014-08-29T06:31:18Z</created-at>
  <updated-at type="dateTime">2026-04-05T14:29:40Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia>Galactitol</wikipedia>
  <uniprot-id nil="true"/>
  <kegg-compound-id>C01697</kegg-compound-id>
  <omim-id nil="true"/>
  <chebi-id>16813</chebi-id>
  <biocyc-id>15-DIDEOXY-15-IMINO-D-GALACTITOL</biocyc-id>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>OC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO</moldb-smiles>
  <moldb-formula>C6H14O6</moldb-formula>
  <moldb-inchi>InChI=1S/C6H14O6/c7-1-3(9)5(11)6(12)4(10)2-8/h3-12H,1-2H2/t3-,4+,5+,6-</moldb-inchi>
  <moldb-inchikey>FBPFZTCFMRRESA-GUCUJZIJSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal">182.1718</moldb-average-mass>
  <moldb-mono-mass type="decimal">182.07903818</moldb-mono-mass>
  <origin>Endogenous</origin>
  <state>Solid</state>
  <logp>-3.1</logp>
  <hmdb-id>HMDB00107</hmdb-id>
  <chembl-id>CHEMBL1773904</chembl-id>
  <chemspider-id>11357</chemspider-id>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference>Muniruzzaman, Syed; Itoh, Hiromichi; Yoshino, Akira; Katayama, Takeshi; Izumori, Ken.  Biotransformation of lactose to galactitol.    Journal of Fermentation and Bioengineering  (1994),  77(1),  32-5. </synthesis-reference>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM003309</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id>NS00074158</susdat-id>
  <iupac nil="true"/>
  <moldb-polar-surface-area>121.38000000000001</moldb-polar-surface-area>
  <moldb-refractivity>38.403600000000004</moldb-refractivity>
  <moldb-polarizability>17.246117178806152</moldb-polarizability>
  <moldb-rotatable-bond-count>5</moldb-rotatable-bond-count>
  <moldb-acceptor-count>6</moldb-acceptor-count>
  <moldb-donor-count>6</moldb-donor-count>
  <moldb-pka-strongest-acidic>12.585200956788803</moldb-pka-strongest-acidic>
  <moldb-pka-strongest-basic>-2.974211614825128</moldb-pka-strongest-basic>
  <moldb-physiological-charge>0</moldb-physiological-charge>
  <moldb-number-of-rings>0</moldb-number-of-rings>
  <moldb-alogps-logp>-2.68</moldb-alogps-logp>
  <moldb-alogps-logs>0.10</moldb-alogps-logs>
  <moldb-alogps-solubility>2.29e+02 g/l</moldb-alogps-solubility>
</compound>
